Hengkang Medical Financials
| 002219 Stock | 2.70 0.02 0.75% |
Operating Margin 0.0402 | PE Ratio 270 | Profit Margin 0.0133 | Return On Equity 0.0262 |
Hengkang | Select Account or Indicator |
Understanding current and past Hengkang Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Hengkang Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Hengkang Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Hengkang Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Hengkang Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Hengkang Medical's management manipulating its earnings.
Hengkang Medical Stock Summary
Hengkang Medical competes with Sichuan Teway, Dhc Software, Guilin Seamild, V V, and Guangdong Advertising. Hengkang Medical is entity of China. It is traded as Stock on SHE exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | China Stock View All |
| Exchange | Shenzhen Stock Exchange |
| ISIN | CNE1000009R5 |
| Business Address | Fortune Financial Center, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.njhtg.com |
| Phone | 86 10 8523 5985 |
You should never invest in Hengkang Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Hengkang Stock, because this is throwing your money away. Analyzing the key information contained in Hengkang Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Hengkang Medical Key Financial Ratios
Hengkang Medical's financial ratios allow both analysts and investors to convert raw data from Hengkang Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Hengkang Medical over time and compare it to other companies across industries.| Revenue | 3.59 B | ||||
| Gross Profit | 992.37 M | ||||
| EBITDA | 422.71 M | ||||
| Net Income | 30.78 M | ||||
| Total Asset | 6.08 B |
Hengkang Medical Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 4.9B | 4.8B | 6.7B | 5.6B | 6.1B | 3.5B | |
| Other Current Liab | 1.5B | 1.6B | 1.7B | 1.3B | 78.3M | 74.3M | |
| Retained Earnings | (2.7B) | (2.7B) | (3.1B) | (3.0B) | (3.1B) | (2.9B) | |
| Accounts Payable | 831.2M | 874.8M | 1.0B | 1.2B | 1.3B | 1.4B | |
| Cash | 122.3M | 171.7M | 2.0B | 558.9M | 580.2M | 405.3M | |
| Long Term Debt | 395.1M | 290.0M | 280.0M | 410.5M | 722.2M | 407.1M | |
| Net Receivables | 825.6M | 568.8M | 710.3M | 754.8M | 1.0B | 622.7M | |
| Inventory | 154.8M | 178.3M | 185.3M | 164.4M | 218.5M | 198.9M | |
| Other Current Assets | 38.5M | 66.2M | 95.2M | 164.5M | 17.1M | 16.2M | |
| Total Liab | 4.7B | 4.7B | 5.1B | 3.9B | 3.8B | 2.1B | |
| Intangible Assets | 300.4M | 270.6M | 274.0M | 265.6M | 304.4M | 248.1M | |
| Other Assets | 199.9M | 168.8M | 196.0M | 220.0M | 253.0M | 265.6M | |
| Other Liab | 173.8M | 262.4M | 140.0M | (1.6M) | (1.8M) | (1.7M) | |
| Good Will | 3.5B | 3.2B | 986.7M | 884.1M | 949.0M | 1.1B | |
| Net Tangible Assets | (1.1B) | (1.1B) | 397.6M | 573.4M | 516.1M | 541.9M | |
| Short Long Term Debt | 1.4B | 1.3B | 1.3B | 314.3M | 716.5M | 1.0B | |
| Total Current Assets | 1.1B | 1.2B | 3.0B | 1.8B | 2.0B | 1.8B | |
| Net Debt | 2.5B | 1.6B | 1.4B | 165.8M | 858.5M | 1.2B | |
| Net Invested Capital | 1.9B | 1.7B | 3.1B | 2.4B | 3.6B | 3.0B | |
| Net Working Capital | (3.0B) | (2.9B) | (1.5B) | (1.5B) | (967.3M) | (1.0B) |
Hengkang Medical Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 344.6M | 136.6M | 230.0M | 142.6M | 120.6M | 72.5M | |
| Net Income | (2.5B) | (52.2M) | (371.4M) | 155.6M | 30.8M | 32.3M | |
| Total Revenue | 3.7B | 2.8B | 3.0B | 3.2B | 3.6B | 3.8B | |
| Operating Income | (221.8M) | 225.8M | 86.3M | 301.2M | 244.4M | 144.7M | |
| Cost Of Revenue | 2.7B | 2.0B | 2.2B | 2.2B | 2.5B | 2.6B | |
| Income Before Tax | (2.4B) | 10.0M | (362.4M) | 187.5M | 10.3M | 10.8M | |
| Income Tax Expense | 53.8M | 60.5M | 52.5M | 4.9M | 5.7M | 5.4M | |
| Minority Interest | 12.7M | 24.0M | (4.1M) | (8.7M) | (8.1M) | (7.7M) | |
| Research Development | 1.3M | 296.9K | 444.5K | 237.9K | 27.7M | 29.1M | |
| Tax Provision | 60.5M | 52.5M | 4.9M | 23.2M | (28.7M) | (27.2M) | |
| Net Interest Income | (346.7M) | (139.9M) | (233.9M) | (132.0M) | (112.1M) | (117.8M) | |
| Interest Income | 2.0M | 71.5K | 948.6K | 11.8M | 11.4M | 6.5M | |
| Gross Profit | 972.5M | 790.7M | 807.7M | 992.6M | 1.1B | 1.0B | |
| Ebit | (840.9M) | 179.3M | (35.6M) | 229.8M | 206.8M | 217.1M | |
| Ebitda | (2.0B) | 317.3M | 30.9M | 496.6M | 571.1M | 599.6M |
Hengkang Medical Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Hengkang Medical. It measures of how well Hengkang is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Hengkang Medical brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Hengkang had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Hengkang Medical has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Capital Expenditures | 215.7M | 216.6M | 198.7M | 221.6M | 195.2M | 160.6M | |
| Net Income | (2.5B) | (52.2M) | (371.4M) | 155.6M | 30.8M | 32.3M | |
| Dividends Paid | 394.9M | 83.9M | 54.2M | 275.8M | 104.0M | 100.9M | |
| Change To Inventory | 67.6M | (23.5M) | (7.3M) | 20.8M | (52.3M) | (49.6M) | |
| Investments | 25.2M | (217.7K) | (1M) | 1M | (335.1M) | (318.4M) | |
| Change In Cash | (214.0M) | 32.1M | 1.8B | (1.5B) | 18.7M | 19.6M | |
| Net Borrowings | (151.7M) | (71.2M) | 30.0M | (1.3B) | (1.1B) | (1.1B) | |
| Depreciation | 134.5M | 170.7M | 163.3M | 155.6M | 217.2M | 188.4M | |
| End Period Cash Flow | 111.3M | 143.4M | 2.0B | 537.9M | 557.0M | 624.1M | |
| Change To Netincome | 2.6B | 123.9M | 499.5M | 132.9M | 119.6M | 113.6M | |
| Free Cash Flow | 333.8M | 67.2M | 78.6M | 46.5M | 95.8M | 100.6M | |
| Other Non Cash Items | 401.3M | 146.0M | 244.8M | 161.3M | 142.1M | 190.8M |
Hengkang Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Hengkang Medical's current stock value. Our valuation model uses many indicators to compare Hengkang Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hengkang Medical competition to find correlations between indicators driving Hengkang Medical's intrinsic value. More Info.Hengkang Medical Group is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.81 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Hengkang Medical Group is roughly 1.24 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Hengkang Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Hengkang Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Hengkang Medical Systematic Risk
Hengkang Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Hengkang Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Hengkang Medical correlated with the market. If Beta is less than 0 Hengkang Medical generally moves in the opposite direction as compared to the market. If Hengkang Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Hengkang Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Hengkang Medical is generally in the same direction as the market. If Beta > 1 Hengkang Medical moves generally in the same direction as, but more than the movement of the benchmark.
Hengkang Medical Group Total Assets Over Time
Hengkang Medical Thematic Clasifications
Hengkang Medical Group is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Hengkang Medical December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Hengkang Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Hengkang Medical Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Hengkang Medical Group based on widely used predictive technical indicators. In general, we focus on analyzing Hengkang Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Hengkang Medical's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.52 | |||
| Information Ratio | 0.1592 | |||
| Maximum Drawdown | 18.08 | |||
| Value At Risk | (5.43) | |||
| Potential Upside | 9.88 |
Complementary Tools for Hengkang Stock analysis
When running Hengkang Medical's price analysis, check to measure Hengkang Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hengkang Medical is operating at the current time. Most of Hengkang Medical's value examination focuses on studying past and present price action to predict the probability of Hengkang Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hengkang Medical's price. Additionally, you may evaluate how the addition of Hengkang Medical to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |